Analyzing Mettler-Toledo International (MTD) & Harvard Bioscience (HBIO)

Mettler-Toledo International (NYSE: MTD) and Harvard Bioscience (NASDAQ:HBIO) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, earnings, valuation and dividends.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Mettler-Toledo International and Harvard Bioscience, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mettler-Toledo International 0 8 3 0 2.27
Harvard Bioscience 0 0 2 0 3.00

Mettler-Toledo International presently has a consensus target price of $631.11, suggesting a potential upside of 10.55%. Harvard Bioscience has a consensus target price of $9.00, suggesting a potential upside of 104.55%. Given Harvard Bioscience’s stronger consensus rating and higher possible upside, analysts clearly believe Harvard Bioscience is more favorable than Mettler-Toledo International.

Insider and Institutional Ownership

92.4% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 68.0% of Harvard Bioscience shares are owned by institutional investors. 4.8% of Mettler-Toledo International shares are owned by insiders. Comparatively, 7.6% of Harvard Bioscience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk and Volatility

Mettler-Toledo International has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Harvard Bioscience has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500.

Valuation & Earnings

This table compares Mettler-Toledo International and Harvard Bioscience’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mettler-Toledo International $2.73 billion 5.32 $375.97 million $17.57 32.49
Harvard Bioscience $101.88 million 1.55 -$860,000.00 $0.05 88.00

Mettler-Toledo International has higher revenue and earnings than Harvard Bioscience. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Harvard Bioscience, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Mettler-Toledo International and Harvard Bioscience’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mettler-Toledo International 13.50% 90.70% 19.26%
Harvard Bioscience -3.70% 2.79% 1.75%

Summary

Mettler-Toledo International beats Harvard Bioscience on 9 of the 14 factors compared between the two stocks.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, physical value analyzers, and thermal analysis systems, as well as other analytical instruments; and LabX, a PC-based laboratory embedded software platform. The company's industrial solutions comprise industrial weighing instruments and terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of multiple weighing and food labeling solutions, stand-alone scales, and networked scales and software for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry covering pharmaceutical and biotechnology companies, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; transportation and logistics, metals, and electronics industries; and the academic community. The company markets its products through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was founded in 1991 and is based in Columbus, Ohio.

Harvard Bioscience Company Profile

Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science basic research, drug discovery, and clinical and environmental testing. The company offers physiology, cell, and molecular instruments, such as traditional syringe pump and peristaltic pump products, as well as a range of instruments and accessories for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, and Hugo Sachs brands; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation instruments that are marketed under the Biochrom, Libra, WPA, BioDrop, Hoefer, Scie-plas, and BTX brand names. It also designs, develops, and manufactures precision electrophysiology equipment specializing in patch clamp amplifiers, and manual and automated patch clamp systems under the HEKA brand; manufactures tools for electrophysiology and cell biology research consisting of cell chambers, perfusion controllers, temperature controllers, microincubation systems, and bio-sensing systems under the Warner Instruments brand; and designs and develops in vivo neural interface systems under the TBSI brand for neuroscience research, primarily in the fields of electrophysiology, psychology, neurology, and pharmacology. In addition, the company is involved in the development and manufacture of precision scientific measuring instrumentation and equipment under the Multi-Channel Systems brand; and physiologic monitoring focused on delivering preclinical products, systems, services, and solutions. Harvard Bioscience, Inc. markets its products in approximately 100 countries through sales organization, Websites, catalogs, and distributors to research scientists at universities, hospitals, government laboratories, and pharmaceutical and biotechnology companies. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply